Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Eikon Therapeutics, Inc. | 134,088 | reported | 02 Mar 2026 | tx 1+134,088 |
| Atara Biotherapeutics, Inc. | 43,500 | reported | 23 Jun 2022 | tx 9+146,500 |
| Nurix Therapeutics, Inc. | 31,250 | reported | 15 May 2026 | tx 3+106,250 |
| Aardvark Therapeutics, Inc. | 30,508 | reported | 11 Jun 2025 | tx 1+30,508 |
| Natera, Inc. | 18,512 | reported | 24 Apr 2026 | tx 62+136,042−110,317 |
| Travere Therapeutics, Inc. | 12,000 | reported | 19 May 2026 | tx 34+217,250−80,500 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 19 May 2026 | GRANT_AWARD | Travere Therapeutics, Inc. | 4,000 | 0.00 USD | |
| 19 May 2026 | GRANT_AWARD | Travere Therapeutics, Inc. | 12,000 | 0.00 USD | deriv |
| 15 May 2026 | GRANT_AWARD | Nurix Therapeutics, Inc. | 31,250 | 0.00 USD | deriv |
| 05 May 2026 | EXERCISE | Travere Therapeutics, Inc. | 4,500 | 18.27 USD | 10b5-1 |
| 05 May 2026 | SALE | Travere Therapeutics, Inc. | 4,500 | 46.65 USD | 10b5-1 |
| 05 May 2026 | EXERCISE | Travere Therapeutics, Inc. | 4,500 | 0.00 USD | 10b5-1deriv |
| 01 May 2026 | EXERCISE | Travere Therapeutics, Inc. | 9,750 | 6.82 USD | 10b5-1 |
| 01 May 2026 | SALE | Travere Therapeutics, Inc. | 9,750 | 44.22 USD | 10b5-1 |
| 01 May 2026 | EXERCISE | Travere Therapeutics, Inc. | 9,750 | 0.00 USD | 10b5-1deriv |
| 24 Apr 2026 | GRANT_AWARD | Natera, Inc. | 83 | — | |
| 02 Mar 2026 | GRANT_AWARD | Eikon Therapeutics, Inc. | 134,088 | 0.00 USD | deriv |
| 30 Jan 2026 | GRANT_AWARD | Natera, Inc. | 70 | — | |
| 20 Nov 2025 | SALE | Natera, Inc. | 1,900 | 223.90 USD | |
| 20 Nov 2025 | SALE | Natera, Inc. | 1,884 | 224.89 USD | |
| 19 Nov 2025 | EXERCISE | Natera, Inc. | 5,112 | 40.93 USD | |
| 20 Nov 2025 | SALE | Natera, Inc. | 1,800 | 222.90 USD | |
| 20 Nov 2025 | SALE | Natera, Inc. | 900 | 221.81 USD | |
| 19 Nov 2025 | SALE | Natera, Inc. | 1,250 | 213.47 USD | |
| 20 Nov 2025 | EXERCISE | Natera, Inc. | 7,068 | 41.19 USD | |
| 20 Nov 2025 | EXERCISE | Natera, Inc. | 600 | 40.93 USD | |
| 19 Nov 2025 | SALE | Natera, Inc. | 2,135 | 216.07 USD | |
| 19 Nov 2025 | SALE | Natera, Inc. | 1,727 | 214.79 USD | |
| 20 Nov 2025 | SALE | Natera, Inc. | 1,184 | 220.14 USD | |
| 20 Nov 2025 | EXERCISE | Natera, Inc. | 7,068 | 0.00 USD | deriv |
| 19 Nov 2025 | EXERCISE | Natera, Inc. | 5,112 | 0.00 USD | deriv |